Nobuyuki Koyama
Kawagoe, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Discrepant CD3+ TILs in PD-L1-Negative NSCLC: Favorable Outcome in an Elderly Patient Treated With Nivolumab, Ipilimumab, and Chemotherapy.
Journal: The American journal of case reports
Published: January 27, 2026
Association of Immune-Related Adverse Events and the Efficacy of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Adjusting for Immortal Time Bias.
Journal: Thoracic cancer
Published: September 21, 2025
Efficacy of Immune Checkpoint Inhibitors in Combination With Platinum-Based Doublet Chemotherapy for Extensive-Stage Small-Cell Lung Cancer Patients With Eastern Cooperative Oncology Group-Performance Status 2-3: A Single-Institution Retrospective Study.
Journal: Cancer medicine
Published: May 06, 2025
Erlotinib-Induced Ocular Cicatricial Pemphigoid in EGFR-Mutated Non-Small Cell Lung Cancer: A Case Report.
Journal: Clinical lung cancer
Published: April 28, 2025
Efficacy of osimertinib resumption with dabrafenib and trametinib for elderly patients with EGFR-mutated lung adenocarcinoma harboring acquired BRAF V600E resistant mutation resistant to osimertinib.
Journal: Japanese journal of clinical oncology
Published: February 16, 2025
Impact of Locoregional Therapies for Brain Lesions on Survival in Patients With Non-small Cell Lung Cancer With Multiple Extrathoracic Metastases.
Journal: Anticancer research
Published: September 14, 2023
Anti-neutrophil cytoplasmic antibody-negative granulomatosis with polyangiitis manifesting through pulmonary nodules and a genital lesion.
Journal: Respiratory medicine case reports
Published: August 23, 2023
Real-World Data Analysis of Pembrolizumab Monotherapy for NSCLC Using Japanese Postmarketing All-Case Surveillance Data.
Journal: JTO clinical and research reports
Published: August 11, 2022
Erratum for Multiple Endocrine Neoplasia Type 1 with Functional Parathyroid Cysts.
Journal: Internal medicine (Tokyo, Japan)
Published: July 31, 2022
Phase I/II study of nedaplatin and nab-paclitaxel for patients with previously untreated advanced squamous cell lung cancer: Kanto Respiratory Disease Study Group (KRSG) 1302.
Journal: International journal of clinical oncology
Published: June 10, 2022
Last Updated: 09/26/2026